argenx to Report Half Year 2024 Financial Results and Second Quarter Business Update on July 25, 2024
18 Julio 2024 - 12:00AM
July 18, 2024Amsterdam,
the Netherlands – argenx (Euronext & Nasdaq: ARGX), a
global immunology company committed to improving the lives of
people suffering from severe autoimmune diseases, today announced
that it will host a conference call and audio webcast on Thursday,
July 25, 2024 at 2:30 PM CET (8:30 AM ET) to discuss its half year
2024 financial results and provide a second quarter business
update.
A webcast of the live call may be accessed on
the Investors section of the argenx website at
argenx.com/investors. A replay of the webcast will be available on
the argenx website for approximately one year following the
presentation.
Dial-in numbers:
Belgium 32 800 50
201France
33 800
943355Netherlands
31 20 795 1090United Kingdom 44 800 358 0970United
States 1 888 415
4250Japan
81 3 4578
9081Switzerland 41
43 210 11 32
Use the access code 3810049 to join the call.
Please dial in 15 minutes prior to the live call.
About argenx
argenx is a global immunology company committed
to improving the lives of people suffering from severe autoimmune
diseases. Partnering with leading academic researchers through its
Immunology Innovation Program (IIP), argenx aims to translate
immunology breakthroughs into a world-class portfolio of novel
antibody-based medicines. argenx developed and is commercializing
the first approved neonatal Fc receptor (FcRn) blocker in the U.S.,
Japan, Israel, the EU, the UK, Canada and China. The Company is
evaluating efgartigimod in multiple serious autoimmune diseases and
advancing several earlier stage experimental medicines within its
therapeutic franchises. For more information, visit www.argenx.com
and follow us on LinkedIn, Twitter, and Instagram.
For further information, please
contact:
Media:
Ben Petokbpetok@argenx.com
Investors:
Alexandra Roy (US)aroy@argenx.com
Lynn Elton (EU)lelton@argenx.com
Argen X (EU:ARGX)
Gráfica de Acción Histórica
De Jul 2024 a Ago 2024
Argen X (EU:ARGX)
Gráfica de Acción Histórica
De Ago 2023 a Ago 2024